New Hampshire bills · 2026 Regular Session
New Hampshire SB 465
classifying xylazine as a schedule III controlled drug.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Bill Gannon (Republican)
Cosponsors (8)
- Jennifer Rhodes (Republican)
- Terry Roy (Republican)
- Lilli Walsh (Republican)
- Mark McConkey (Republican)
- David Rochefort (Republican)
- Sharon Carson (Republican)
- Regina Birdsell (Republican)
- Daryl Abbas (Republican)
Summary
No official summary is available for this bill.
Latest action(Apr 23, 2026): Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 23, 2026 · House
Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55 - Apr 15, 2026 · House
Minority Committee Report: Ought to Pass - Apr 15, 2026 · House
Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC) - Apr 8, 2026 · House
Executive Session: 04/14/2026 01:00 pm GP 153 - Apr 1, 2026 · House
Full Committee Work Session: 04/07/2026 01:00 pm GP 153 - Mar 18, 2026 · House
Public Hearing: 03/31/2026 01:30 pm GP 153 - Mar 16, 2026 · House
Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8 P. 114 - Feb 24, 2026 · Senate
Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5 - Feb 24, 2026 · Senate
Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5 - Feb 20, 2026 · Senate
Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8 - Feb 5, 2026 · Senate
Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A - Nov 21, 2025 · Senate
Introduced 01/07/2026 and Referred to Judiciary; SJ 1